Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,027 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Electrophysiological properties of prion-positive cardiac progenitors derived from murine embryonic stem cells.
Fujii H, Ikeuchi Y, Kurata Y, Ikeda N, Bahrudin U, Li P, Nakayama Y, Endo R, Hasegawa A, Morikawa K, Miake J, Yoshida A, Hidaka K, Morisaki T, Ninomiya H, Shirayoshi Y, Yamamoto K, Hisatome I. Fujii H, et al. Among authors: hasegawa a. Circ J. 2012;76(12):2875-83. doi: 10.1253/circj.cj-12-0126. Epub 2012 Sep 4. Circ J. 2012. PMID: 22972200 Free article.
Uric Acid-Induced Enhancements of Kv1.5 Protein Expression and Channel Activity via the Akt-HSF1-Hsp70 Pathway in HL-1 Atrial Myocytes.
Taufiq F, Maharani N, Li P, Kurata Y, Ikeda N, Kuwabara M, Otani N, Miake J, Hasegawa A, Tsuneto M, Shirayoshi Y, Ninomiya H, Saitoh T, Nakai A, Yamamoto K, Hisatome I. Taufiq F, et al. Among authors: hasegawa a. Circ J. 2019 Mar 25;83(4):718-726. doi: 10.1253/circj.CJ-18-1088. Epub 2019 Feb 20. Circ J. 2019. PMID: 30787218 Free article.
Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone.
Suzuki S, Kurata Y, Li P, Notsu T, Hasegawa A, Ikeda N, Kato M, Miake J, Sakata S, Shiota G, Yoshida A, Ninomiya H, Higaki K, Yamamoto K, Shirayoshi Y, Hisatome I. Suzuki S, et al. Among authors: hasegawa a. Eur J Pharmacol. 2012 Dec 5;696(1-3):28-34. doi: 10.1016/j.ejphar.2012.09.025. Epub 2012 Sep 28. Eur J Pharmacol. 2012. PMID: 23026372
Simultaneous treatment with azelnidipine and olmesartan inhibits apoptosis of Hl-1 cardiac myocytes expressing E334k cMyBPC.
Bahrudin U, Ikeda N, Utami SB, Maharani N, Morikawa K, Li P, Sobirin MA, Hasegawa A, Sakata S, Endo R, Rifqi S, Shirayoshi Y, Yamamoto K, Ninomiya H, Hisatome I. Bahrudin U, et al. Among authors: hasegawa a. Drug Res (Stuttg). 2013 Oct;63(10):515-20. doi: 10.1055/s-0033-1347188. Epub 2013 Jun 5. Drug Res (Stuttg). 2013. PMID: 23740383
Effects of cilnidipine on serum uric acid level and urinary nitrogen monoxide excretion in patients with hypertension.
Hamada T, Yamada K, Mizuta E, Watanabe A, Osaki T, Ishida K, Hasegawa A, Sakata S, Mishima M, Ogino K, Nosaka Y, Miyazaki S, Ohtahara A, Ninomiya H, Kato M, Yoshida A, Taniguchi S, Yamamoto K, Hisatome I. Hamada T, et al. Among authors: hasegawa a. Clin Exp Hypertens. 2012;34(7):470-3. doi: 10.3109/10641963.2012.666600. Epub 2012 Jun 8. Clin Exp Hypertens. 2012. PMID: 22681507 Free article.
A vasodilating β1 blocker celiprolol inhibits muscular release of uric acid precursor in patients with essential hypertension.
Mizuta E, Utami SB, Ohtahara A, Endo S, Mishima M, Hasegawa A, Yamada K, Kato M, Yamamoto K, Ogino K, Ninomiya H, Miyazaki S, Hamada T, Taniguchi SI, Cheng J, Hisatome I. Mizuta E, et al. Among authors: hasegawa a. Horm Metab Res. 2013 Jan;45(1):69-73. doi: 10.1055/s-0032-1321872. Epub 2012 Aug 14. Horm Metab Res. 2013. PMID: 22893261 Clinical Trial.
2,027 results